bevacizumabNelmastobarttrifluridine/tipiracilmCRCMetastatic colorectal cancer (mCRC)
… 52.1%.Conclusions Nelmastobart plus trifluridine/tipiracil and bevacizumab was well tolerated, with no drug-related toxicities. BTN1A1 exp…
3articles mentioning drugs
8drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: trifluridine/tipiracil ×
trifluridine/tipiracil
This drug is selected. Its supporting articles are shown below.
Articles mentioning trifluridine/tipiracil
3 articles · page 1 of 1bevacizumabtrifluridine/tipiracilBev-TASmCRCmetastatic colorectal cancersecond-level hospital
…in the pivotal SUNLIGHT trial, supporting the benefit of adding bevacizumab to trifluridine/tipiracil in real-world practice. Safety profil…
bevacizumabTAStrifluridine/tipiracilBEVColorectal cancermCRCEastern Cooperative Oncology Group
…remains uncertain.Therapy with trifluridine/tipiracil (TAS) and bevacizumab (TAS+BEV) has been evaluated in phase III SUNLIGHT trial, demon…